| Small molecule CGRP receptor antagonist |
| Available as an orally disintegrating tablet formulation |
| Relieves pain and the most bothersome symptom when taken as needed for the acute treatment of migraine |
| Reduces migraine frequency when taken every other day for the preventive treatment of migraine |
| Generally well tolerated |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.